U.S. Stockpiles $290 Million in NIH-Funded Radiation Sickness Drug
The Biden administration this week purchased $290 million worth of Nplate, a radiation sickness drug — with serious side effects — developed by drugmaker Amgen in partnership with several government agencies, including the National Institute of Allergy and Infectious Diseases, headed by Dr...
childrenshealthdefense.org